Roundup's Billion-Dollar Blood Money Payout: Cancer Victims Paid Off
Bayer agrees to a massive $7.25 billion settlement over Roundup cancer claims, ending a long legal battle while denying the weedkiller causes illness.

In a stunning courtroom gambit that reeks of hush money, embattled German bio-tech behemoth Bayer has finally, grudgingly, opened its cavernous coffers. A Missouri judge, in a move dripping with resignation, just sanctioned a staggering $7.25 billion settlement for the legions of cancer-stricken souls who claim Bayer’s iconic weedkiller, Roundup, poisoned them. This isn’t justice; it’s a corporate-funded ceasefire after a decade-long war of attrition.
Call it what you will—a ‘fair, reasonable, and adequate’ conclusion according to the judge—but the stench of glyphosate and regret is palpable. This payoff, spanning a jaw-dropping 21 years of annual payments, is a desperate bid to stanch the bleeding from a brand hemorrhaging credibility and cash. Let’s be clear: Bayer denies, denies, denies that its garden-variety assassin causes the hellish non-Hodgkin lymphoma plaguing its users. Yet here they are, forking over another mountain of cash on top of the $10 billion already spent to make the lawsuits… disappear.
The payouts, ranging from a paltry $10,000 to $165,000, are being parceled out based on a morbid calculus: how much you sprayed, when death’s diagnosis arrived, and just how cruelly the illness ravaged you. Some lawyers wept that it wasn’t enough, but the judge, staring at the terminally ill lined up at death’s door, chose a bird in the hand. Meanwhile, a ghost haunts the halls: Monsanto, Roundup’s original 1970s architect, now a spectral subsidiary within Bayer’s empire.
This settlement arrives hot on the heels of a Supreme Court gift to Bayer, a ruling that shielded them from state-level claims. It’s a brutal tango—one step forward for victims, two steps back in the regulatory waltz. The World Health Organization branded glyphosate a ‘probable human carcinogen’ nearly a decade ago, a finding Bayer and its friends at the U.S. EPA bitterly contest. Yet juries across America, persuaded by the human toll, have repeatedly handed down billion-dollar verdicts. This $7.25bn isn’t an admission; it’s the cost of doing business when your business might just be killing your customers.
Original article: BBC News ▸



